<DOC>
	<DOCNO>NCT00777322</DOCNO>
	<brief_summary>The purpose study determine whether excimer laser corneal surface ablation ( T−Cat ) safely combine simultaneous corneal collagen cross−linking treatment produce improve stable corneal profile treatment keratoconus .</brief_summary>
	<brief_title>T-Cat Laser &amp; Cross-linking Keratoconus</brief_title>
	<detailed_description>Theoretical framework : Corneal ectasia relative weakness structure cornea , produce progressive change shape resultant visual distortion . Excimer laser surface ablation use re−shape corneal profile . When corneal shape irregular , corneal topography data give best information re−shape cornea normal profile , Topography−Computer Assisted Treatment ( T−Cat ) use modulate surface corneal shape . It known collagen cross−linking cornea occur naturally age , diabetes , seem prevent progressive ectasia . Corneal collagen cross−linking riboflavin show stabilize cornea keratoconus , prevent progression disease . If cross−linking perform moment cornea re−shaped T−Cat treatment , help prevent corneal thin resultant laser treatment destabilise cornea cause progressive ectasia . Purpose : To determine whether excimer laser corneal surface ablation ( T−Cat ) safely combine simultaneous corneal collagen cross−linking treatment produce improve stable corneal profile . Design : Prospective , interventional trial .</detailed_description>
	<mesh_term>Keratoconus</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Patients know keratoconus pellucid marginal degeneration . Age &lt; 18 year &gt; 50 year . Minimal corneal pachymetry eye treat &lt; 400μ . Evidence corneal disease eye treat ( e.g . Herpes simplex keratitis ) . Women pregnant nursing time initial treatment . Presence significant central corneal opacity . Patients unwilling wear rigid contact lenses eye operate least one month baseline examination , first six month post−operatively .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>keratoconus</keyword>
	<keyword>pellucid marginal degeneration</keyword>
	<keyword>corneal ectasia</keyword>
	<keyword>collagen cross-linking</keyword>
	<keyword>riboflavin</keyword>
	<keyword>UV light</keyword>
	<keyword>excimer laser</keyword>
	<keyword>Topography-Computer Assisted Treatment ( T-Cat )</keyword>
	<keyword>Wavelight Allegretto laser</keyword>
</DOC>